Skip to content

A Clinical Evaluation of Homeopathic Remedies in Dermatitis Management

A Clinical Study on the Efficacy of Graphites, Sulphur, and Natrum Muriaticum in the Homeopathic Management of Dermatitis Using the SCORAD Index. - NORMAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/109998
Enrollment
60
Registered
2026-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Graphites, Sulphur and Natrum Muriaticum: Dose and repetition as per the intensity of the symptoms. Control Intervention1: Not applicable: Not applicable

Sponsors

L.R.Shah Homoepathic College, Rajkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both sexes, aged between 18 and 60 years. Clinically diagnosed cases of Dermatitis (Atopic, Contact, Seborrheic, etc.). Patients willing to take only homoeopathic medicine. Patients who provide written informed consent for the study.

Exclusion criteria

Exclusion criteria: - Patients with severe systemic illness or dermatological emergencies like severe drug reaction. - Patient who is pregnant and lactating women. - Patients currently using topical or systemic steroids or immunosuppressants. - Patients who are unwilling to provide consent or are not likely to be compliant with follow- up. - Patients with infectious skin conditions (e.g., fungal, bacterial, or viral infections) that may confound the diagnosis or outcomes.

Design outcomes

Primary

MeasureTime frame
This study is expected to demonstrate the therapeutic potential of Graphites, Sulphur, and Natrum Muriaticum in the management of Dermatitis. The findings could provide valuable evidence for homoeopaths in clinical practice, encourage further research in the field, and present homoeopathy as a viable and safe treatment option for patients suffering from Dermatitis.Timepoint: 1 Year

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Salma Gandhi

L.R.Shah Homoepathy College

drjayantanandi@gmail.com8777451964

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026